Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
Human Urinary Kallidinogenase
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Acute Ischemic Stroke
1 trial -
Human umbilical cord mesenchymal stem cells
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Knee Osteoarthritis
1 trial -
Huoluo Pills
Universal Integrated
Rheumatoid Arthritis
1 trial -
Hydrochloride anlotinib
Zhongnan Hospital
Uterine Cervical Neoplasms
1 trial -
Hydrochlorothiazide, Captopril, Nitrendipine, Aspirin
The First People's Hospital of Lianyungang
Hypertension
1 trial -
Hydroxychloroquine Sulfate 200 MG [Plaquenil]
BRIGHT MINDS BIOSCIENCES INC.
Coronavirus Infection
1 trial -
Hydroxyurea
United Therapeutics Europe Ltd
Thrombocythemia
1 trial -
Hypofractionated Radiation Therapy
The First People's Hospital of Lianyungang
Breast Cancer
1 trial -
Hypofractionated radiotherapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lung Cancer
1 trial -
Ibuprofen
United Therapeutics Europe Ltd
Immune System and Related Disorders
1 trial -
Immediate CEUS
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Liver Cancer
1 trial -
Immune-enhancing nutritional beverage
United Therapeutics Europe Ltd
Mitigation of Immune Function Decrements in Response to Stress
1 trial -
Immunohistochemistry or genetic test
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Glioma
1 trial -
Immunosuppressive therapy
Xiyuan Hospital of China Academy of Chinese Medical Sciences
In-stent Restenosis Lesion
1 trial -
Improved warm meridians and relieve pain plaster
Universal Integrated
Pelvic Inflammatory Disease
1 trial -
Inactivated influenza vaccine
The University of Hong Kong
Influenza Virus Infection
1 trial -
Indomethacin and Ibuprofen
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ductus Arteriosus, Patent
1 trial -
Induction therapy-2 cycles of VPX (Teniposide, PD-1 monoclonal antibody plus Selinixor)
The First People's Hospital of Lianyungang
Primary Central Nervous System Lymphoma (PCNSL)
1 trial -
Infant and young child feeding
United Therapeutics Europe Ltd
Growth; Stunting, Nutritional
1 trial -
Inhaled Placebo
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ventilator-Associated Pneumonia (VAP)
1 trial -
Inhaled corticosteriod/long-acting beta-agonist plus Montelukast
Second Affiliated Hospital, School of Medicine, Zhejiang University
Asthma
1 trial -
Innovative Dietary Formulation (Patent ID: CN110250417A)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Hypertension
1 trial -
Insulin
The First People's Hospital of Lianyungang
Gestational Diabetes
1 trial -
Insulin
United Therapeutics Europe Ltd
Burns
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources